Valero and Par Pacific upgraded, Phillips 66 cut at Piper Sandler in shift of refiner ratings
Valero Energy (NYSE:VLO) +1.4% and Par Pacific (PARR) +3% in Friday's trading as Piper Sandler upgrades both stocks to ...
Nektar Therapeutics (NKTR) Gets a Buy from Piper Sandler
Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Nektar Therapeutics (NKTR – Research Report) today and set a price target of ...
Piper initiates on soda stocks; Pepsi, Coca-Cola ‘overweight,’ Dr Pepper ‘neutral'
Piper Sandler initiated coverage on soda stocks, rating PepsiCo (NASDAQ:PEP), Coca-Cola (NYSE:KO) “overweight,” and Neutral on Keurig Dr Pepper (NASDAQ:KDP).
Coca-Cola and PepsiCo land bull ratings at Piper Sandler
Piper Sandler dipped into the beverage sector on Tuesday by issuing new Overweight ratings on Coca-Cola (NYSE:KO) and PepsiCo ...
Yahoo Finance5d
Piper Sandler Companies (PIPR)
LONDON, January 06, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Paul Leece, Jeremi Martin and Daniel Allmomen to its energy ...
Kenvue stock still has 'ample room': Piper Sandler
Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...
Amplitude, Asana see bullish views at Piper Sandler, stocks climb
Piper Sandler upgraded Amplitude and Asana to Overweight from Neutral, while highlighting trends for the software industry.
BlackLine (NASDAQ:BL) Cut to Underweight at Piper Sandler
BlackLine (NASDAQ:BL – Get Free Report) was downgraded by analysts at Piper Sandler from a “neutral” rating to an “underweight” rating in a research report issued on Monday,Finviz reports. They ...
Nasdaq1mon
Poseida Therapeutics downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Poseida Therapeutics (PSTX) to Neutral from Overweight with an unchanged price target of $10 following Roche’s announced acquisition for $9 per share in cash and $4 per ...
We are focusing more on quality value than quality growth this year, says Piper Sandler's Kantrowitz
Michael Kantrowitz, Piper Sandler chief investment strategist, joins 'The Exchange' to discuss why higher rates pose the biggest risks to markets and more.